A 67-year-old with type 2 diabetes and established ASCVD has A1C 7.5% on metformin. Which addition provides cardiovascular benefit independent of A1C?...

Question

A 67-year-old with type 2 diabetes and established ASCVD has A1C 7.5% on metformin. Which addition provides cardiovascular benefit independent of A1C?

Accepted Answer

GLP-1 receptor agonist with CV benefit or SGLT2 inhibitor

Answer

Sulfonylurea

Answer

Pioglitazone

Answer

Basal insulin

Answer

Alpha-glucosidase inhibitor

us-abfm MCQ (SBA): Type 2 Diabetes with ASCVD

A 67-year-old with type 2 diabetes and established ASCVD has A1C 7.5% on metformin. Which addition provides cardiovascular benefit independent of A1C?